Evidence map›Paper›PMID 40025466›Full record

ArticleBMC veterinary research2025

Microencapsulated rrBNGF as an alternative ovulation induction method in rabbits.

Alejandra C Quiroga, Silvia Gimeno-Martos, Pedro L Lorenzo, María Arias Álvarez, Pilar G Rebollar, Rosa M García-García

Abstract read
In one paragraph

Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alejandra C QuirogaDepartment of Physiology, Veterinary Faculty, Complutense University of Madrid, 28040, Madrid, Spain. alequirogario@gmail.com.
Silvia Gimeno-MartosDepartment of Physiology, Veterinary Faculty, Complutense University of Madrid, 28040, Madrid, Spain.
Pedro L LorenzoDepartment of Physiology, Veterinary Faculty, Complutense University of Madrid, 28040, Madrid, Spain.
María Arias ÁlvarezDepartment of Animal Production, Veterinary Faculty, Complutense University of Madrid, 28040, Madrid, Spain.
Pilar G RebollarDepartment of Agrarian Production, ETSIAAB, Universidad Politécnica de Madrid, 28040, Madrid, Spain. pilar.grebollar@upm.es.
Rosa M García-GarcíaDepartment of Physiology, Veterinary Faculty, Complutense University of Madrid, 28040, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRabbits are an induced-ovulatory species such that exogenous hormone factors are needed to induce ovulation. Traditionally, intramuscular injections of gonadotropin-releasing hormone (GnRH) analogues are given at the time of artificial insemination (AI). To avoid the need for injections, the intravaginal delivery of molecules naturally present in seminal plasma has been explored. Here, we examined the possibility of using nerve growth factor (NGF) microencapsulated with chitosan to induce ovulation. First, the biological activity of these NGF microcapsules was assessed in pheochromocytoma of rat adrenal medulla cell (PC12) cultures, along with their effects on semen. Next, we examined the ability of the intravaginal NGF-chitosan delivery system administered at AI (NGFch-0) or 30 min before AI (NGFch-30) to elicit ovulation. To this end, progesterone concentrations on Day 7 post AI, pregnancy rates and prolificacy (kits born alive and stillbirths per doe) were determined in nulliparous and multiparous rabbit does and then compared amongst treatments: intravaginal NGFch-0 and NGFch-30, intramuscular injection of GnRH analogue, intravaginal empty-catheter (C-e) or intravaginal semen-containing catheter (C-s).

resultsNGF-chitosan promoted similar PC12 differentiation to free NGF without impairing cell viability. The presence of the NGF-containing microcapsules did not interfere with semen motility, viability or capacitation status. In our in vivo experiments, nulliparous rabbits showed similar rates of ovulating females across treatments (GnRH 90%, NGFch-30 100%, NGFch-0 66.7%, C-e 83.3%), yet higher pregnancy rates were observed in response to GnRH and NGFch-30 (90% and 100%, respectively) than to NGFch-0 (60%). Prolificacy results in these does were similar across treatments. In multiparous does, GnRH treatment gave rise to the highest rate of ovulating female and pregnancy rates (100 and 90%, respectively). In contrast, the NGF-chitosan groups showed the lowest ovulating female and pregnancy rates (NGFch-30 50% and 25%, NGFch-0 41.7% and 21%, respectively). An intermediate ovulatory response was obtained in does stimulated with the catheter (C-e 70%, C-s 57.1%), and a pregnancy rate of 20% was obtained if the catheter contained diluted semen (C-s).

conclusionsIntravaginal NGF-chitosan administered 30 min before AI induced ovulation at a similar rate to GnRH injection in nulliparous, but not multiparous, rabbit females. A better receptivity status of nulliparous females could be a determining factor for this response. However, mechanical stimulation gave rise to a high ovulation rate, so this could be masking or, in some cases, directly replacing the NGF-chitosan effect.

Indexed as

Nerve Growth FactorOvulation InductionAdministration, IntravaginalAnimalsCapsulesChitosanFemaleInsemination, ArtificialMaleOvulationPC12 CellsPregnancyProgesteroneRabbitsRatsSemenCapsulesChitosanNerve Growth FactorProgesteroneChitosanFertilityNGFOvulationPC12 cellsProgesteroneProlificacyRabbitSemen

Identifiers

PMID40025466
PMCPMC11874391

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.